Westfield Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Westfield Capital Management's BSX Position: Q2 2026 in Review
Westfield Capital Management increased its Boston Scientific (BSX) stake by 476% in Q2 2026, buying an estimated $1.54M and bringing the position to 34,378 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #260.
Westfield Capital Management first reported a position in BSX in Q3 2019 and has held it in 18 quarters since. The position peaked at $125M in Q4 2020. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Westfield Capital Management held 34,378 shares of Boston Scientific worth $1.47M as of Q2 2026.
- Westfield Capital Management bought 28,413 Boston Scientific shares in Q2 2026, an estimated $1.54M.
- Boston Scientific made up ﹤0.01% of Westfield Capital Management's portfolio in Q2 2026, its #260 holding.
- Westfield Capital Management first reported a position in Boston Scientific in Q3 2019 and has held it in 18 quarters since.
- Westfield Capital Management's Boston Scientific position peaked at $125M in Q4 2020.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.